Cargando…
Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
Growing evidence supports a mutual relationship between inflammation and major depression. A variety of mechanisms are outlined, indicating how inflammation may be involved in the pathogenesis, course and treatment of major depression. In particular, this review addresses 1) inflammatory cytokines a...
Autores principales: | Schmidt, Frank M., Kirkby, Kenneth C., Lichtblau, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050395/ https://www.ncbi.nlm.nih.gov/pubmed/26769225 http://dx.doi.org/10.2174/1570159X14666160115130414 |
Ejemplares similares
-
New Molecular Targets for Antidepressant Drugs
por: Kornhuber, Johannes, et al.
Publicado: (2021) -
Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
por: Jha, Manish K., et al.
Publicado: (2018) -
Impact of Antidepressants on Cytokine Production of Depressed Patients in Vitro
por: Munzer, Alexander, et al.
Publicado: (2013) -
Galanin Receptors as Drug Target for Novel Antidepressants: Review
por: Demsie, Desalegn Getnet, et al.
Publicado: (2020) -
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021)